Skip to content
Menu

BridgeBio Oncology Therapeutics, Inc. BBOT

Full chart Compare
Set alert

Price alert · BBOT

All alert types
1.81 USD -0.05 (-2.69%)

Regular-session close

1.81 0.00 0.00%

After hours · Nov 20, 4:00 PM ET

1.79 Day range 1.94
1.80 52-week range 13.69
YTD
-85.54%
1 year
-85.14%

BBOT free cash flow history

Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.

-114,500,000 USD

FY 2025 · Period ended

Coverage: incomplete. Values in USD; not inflation adjusted.

Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.

Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.

Scroll the table to see all values →

Free cash flow · annual · USD
Fiscal periodPeriod endFree cash flowYoY changeYoY %
FY 20252025-12-31-114,500,000-59,424,000Not meaningful
FY 20242024-12-31-55,076,000-2,583,000Not meaningful
FY 20232023-12-31-52,493,000-52,493,000Not meaningful
FY 20222022-12-310Not availableNot available

Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.

Company-reported financial statements. Retrieved 2026-05-22T14:42:37.000Z. Retrieval time is not a report date.

Open full statements

Use Add to watchlist above to save this stock.